Infant Aphakia Treatment Study (IATS)
Sponsor: Alcon Research
A NA clinical study on Congenital Cataract, this trial is completed. The trial is conducted by Alcon Research and has accumulated 16 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Aug 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2024 — Aug 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 11 earlier versions
-
Sep 2022 — Dec 2022 [monthly]
Completed NA
-
Dec 2021 — Sep 2022 [monthly]
Completed NA
-
Nov 2021 — Dec 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Apr 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Completed → Active Not Recruiting · Phase: PHASE3 → NA
-
Feb 2017 — Mar 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Dec 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alcon Research
- BSN-JOBST Inc.
- Bausch & Lomb Incorporated
- Eye Care and Cure
- National Eye Institute (NEI)
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Atlanta, United States, Boston, United States, Charleston, United States, Cleveland, United States, Dallas, United States, Durham, United States, Houston, United States, Indianapolis, United States, Miami, United States, Minneapolis, United States and 3 more location s